Endocrinology and Autoimmune Diabetes

Authors

  • Rasha Majid Abd Ulameer Alhumairi Department of Biology, College of Science for Women, University of Baghdad, IRAQ.
  • Shaymaa I K Aljuboori Department of Biology, College of Science for Women, University of Baghdad, IRAQ.
  • Tara Aso Taher Department of Biology, College of Science for Women, University of Baghdad, IRAQ.
  • Zeena Tariq Sabaar Department of Biology, College of Science for Women, University of Baghdad, IRAQ.

DOI:

https://doi.org/10.55544/sjmars.3.5.10

Keywords:

Endocrinology, Diabetes, Thyrotoxicosis

Abstract

Therapists within the constantly evolving area of endocrinology, including diabetes treatment in especially, have to rapidly incorporate novel knowledge into their daily practice. Endocrinology is a field of medical or physiology that examines the endocrine system, including its hormonal substances, or disorders. It is structured in an interesting, individualized manner. A frequent endocrine condition that impacts the amount of sugar in the blood called diabetes. There are some linked facts regarding endocrinology as well as diabetes: this style gives readers an additional accessible or targeted method to quickly answer particular medical issues by listing them. This extensive written content, which encompasses the most prevalent medical challenges in endocrinology or diabetes, has been created by a famous, worldwide panel of specialists. Endocrinologists, diabetic specialists, internal health medical professionals, general doctors, fellows, or resident would all find it very interesting.

References

[1] Cavalu, S.; Simon, V. Proteins adsorption to othopaedic biomaterials: Vibrational spectroscopy evidence. J. Optoelectron. Adv. Mater. 2007, 9, 3297–3302.

[2] Kota, S.K.; Meher, L.K.; Jammula, S.; Kota, S.K.; Modi, K.D. Clinical Profile of Coexisting Conditions in Type 1 Diabetes Mellitus Patients. Diabetes Metab. Syndr. 2012, 6, 70–76.

[3] Hollowell, J.G.; Staehling, N.W.; Dana Flanders, W.; Harry Hannon, W.; Gunter, E.W.; Spencer, C.A.; Braverman, L.E. Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 2002, 87, 489–499.

[4] Franco, J.-S.; Amaya-Amaya, J.; Anaya, J.-M. Thyroid Disease and Autoimmune Diseases. In Autoimmunity: From Bench to Bedside; El Rosario University Press: Bogotá, Colombia, 2013.

[5] Kordonouri, O.; Hartmann, R.; Deiss, D.; Wilms, M.; Grüters-Kieslich, A. Natural Course of Autoimmune Thyroiditis in Type 1 Diabetes: Association with Gender, Age, Diabetes Duration, and Puberty. Arch. Dis. Child. 2005, 90, 411–414.

[6] Kakleas, K.; Soldatou, A.; Karachaliou, F.; Karavanaki, K. Associated Autoimmune Diseases in Children and Adolescents with Type 1 Diabetes Mellitus (T1DM). Autoimmun. Rev. 2015, 14, 781–797.

[7] Furuya, F.; Shimura, H.; Yamashita, S.; Endo, T.; Kobayashi, T. Liganded Thyroid Hormone Receptor-α Enhances Proliferation of Pancreatic β-Cells. J. Biol. Chem. 2010, 285, 24477–24486.

[8] Fukuchi, M.; Shimabukuro, M.; Shimajiri, Y.; Oshiro, Y.; Higa, M.; Akamine, H.; Komiya, I.; Takasu, N. Evidence for a Deficient Pancreatic β-Cell Response in a Rat Model of Hyperthyroidism. Life Sci. 2002, 71, 1059–1070.

[9] Duntas, L.H.; Orgiazzi, J.; Brabant, G. The Interface between Thyroid and Diabetes Mellitus. Clin. Endocrinol. 2011, 75, 1–9.

[10] Chantzichristos, D.; Eliasson, B.; Johannsson, G. Management of Endocrine Disease: Disease Burden and Treatment Challenges in Patients with Both Addison’s Disease and Type 1 Diabetes Mellitus. Eur. J. Endocrinol. 2020, 183, R1–R11.

[11] Elbelt, U.; Hahner, S.; Allolio, B. Altered Insulin Requirement in Patients with Type 1 Diabetes and Primary Adrenal Insuffciency Receiving Standard Glucocorticoid Replacement Therapy. Eur. J. Endocrinol. 2009, 160, 919–924.

[12] Lankisch, T.O.; Jaeckel, E.; Strassburg, C.P. The Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy or Autoimmune Polyglandular Syndrome Type 1. Semin. Liver Dis. 2009, 29, 307–314.

[13] Fierabracci, A. Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A “Rare” Manifestation in a “Rare” Disease. Int. J. Mol. Sci. 2016, 17, 1106.

[14] Alimohammadi, M.; Björklund, P.; Hallgren, Å.; Pöntynen, N.; Szinnai, G.; Shikama, N.; Keller, M.P.; Ekwall, O.; Kinkel, S.A.; Husebye, E.S.; et al. Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen. N. Engl. J. Med. 2008, 358, 1018–1028.

[15] Kahaly, G.J.; Frommer, L.; Schuppan, D. Celiac Disease and Glandular Autoimmunity. Nutrients 2018, 10, 814.

[16] Holmes, G.K.T. Coeliac Disease and Type 1 Diabetes Mellitus—The Case for Screening. Diabet. Med. 2001, 18, 169–177.

[17] Cerutti, F.; Bruno, G.; Chiarelli, F.; Lorini, R.; Meschi, F.; Sacchetti, C. Younger Age at Onset and Sex Predict Celiac Disease in Children and Adolescents with Type 1 Diabetes: An Italian Multicenter Study. Diabetes Care 2004, 27, 1294–1298.

[18] Bratanic, N.; Smigoc Schweiger, D.; Mendez, A.; Bratina, N.; Battelino, T.; Vidan-Jeras, B. An Influence of HLA-A, B, DR, DQ, and MICA on the Occurrence of Celiac Disease in Patients with Type 1 Diabetes. Tissue Antigens 2010, 76, 208–215.

[19] Norris, J.M.; Barriga, K.; Klingensmith, G.; Hoffman, M.; Eisenbarth, G.S.; Erlich, H.A.; Rewers, M. Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity. JAMA 2003, 290, 1713–1720.

[20] Yeung, W.C.G.; Rawlinson, W.D.; Craig, M.E. Enterovirus Infection and Type 1 Diabetes Mellitus: Systematic Review and Meta-Analysis of Observational Molecular Studies. BMJ 2011, 342, d35.

[21] Stene, L.C.; Honeyman, M.C.; Hoffenberg, E.J.; Haas, J.E.; Sokol, R.J.; Emery, L.; Taki, I.; Norris, J.M.; Erlich, H.A.; Eisenbarth, G.S.; et al. Rotavirus Infection Frequency and Risk of Celiac Disease Autoimmunity in Early Childhood: A Longitudinal Study. Am. J. Gastroenterol. 2006, 101, 2333–2340.

[22] Kemppainen, K.M.; Ardissone, A.N.; Davis-Richardson, A.G.; Fagen, J.R.; Gano, K.A.; León-Novelo, L.G.; Vehik, K.; Casella, G.; Simell, O.; Ziegler, A.G.; et al. Early Childhood Gut Microbiomes Show Strong Geographic Differences among Subjects at High Risk for Type 1 Diabetes. Diabetes Care 2015, 38, 329–332.

[23] Bhadada, S.K.; Kochhar, R.; Bhansali, A.; Dutta, U.; Kumar, P.R.; Poornachandra, K.S.; Vaiphei, K.; Nain, C.K.; Singh, K. Prevalence and Clinical Profile of Celiac Disease in Type 1 Diabetes Mellitus in North India. J. Gastroenterol. Hepatol. 2011, 26, 378–381.

[24] Diamanti, A.; Capriati, T.; Basso, M.S.; Panetta, F.; Laurora, V.M.D.C.; Bellucci, F.; Cristofori, F.; Francavilla, R. Celiac Disease and Overweight in Children: An Update. Nutrients 2014, 6, 207–220.

[25] Cavalu, S.; Popa, A.; Bratu, I.; Borodi, G.; Maghiar, A. New Evidences of Key Factors Involved in “Silent Stones” Etiopathogenesis and Trace Elements: Microscopic, Spectroscopic, and Biochemical Approach. Biol. Trace Elem. Res. 2015, 168, 311–320.

[26] De Block, C.E.M.; Van Campenhout, C.M.; De Leeuw, I.H.; Keenoy, B.M.Y.; Martin, M.; Van Hoof, V.; Van Gaal, L.E. Soluble Transferrin Receptor Level: A New Marker of Iron Deficiency Anemia, a Common Manifestation of Gastric Autoimmunity in Type 1 Diabetes. Diabetes Care 2000, 23, 1384–1388.

[27] Modlin, I.M.; Kidd, M.; Latich, I.; Zikusoka, M.N.; Shapiro, M.D. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005, 128, 1717–1751.

[28] Esteban, L.M.; Baxter, A.G. Polyspecificity of Autoimmune Responses in Type 1 (Autoimmune) Diabetes. Clin. Exp. Immunol. 2001, 126, 184–186.

[29] Kakleas, K.; Kostaki, M.; Critselis, E.; Karayianni, C.; Giannaki, M.; Anyfantakis, K.; Haramaras, I.; Fotinou, A.; Papathanasiou, A.; Karavanaki, K. Gastric Autoimmunity in Children and Adolescents with Type 1 Diabetes: A Prospective Study. Horm. Res. Paediatr. 2012, 77, 121–126.

[30] Lima, A.L.; Illing, T.; Schliemann, S.; Elsner, P. Cutaneous Manifestations of Diabetes Mellitus: A Review. Am. J. Clin. Dermatol. 2017, 18, 541–553.

[31] Passanisi, S.; Salzano, G.; Lombardo, F. Skin Involvement in Paediatric Patients with Type 1 Diabetes. Curr. Diabetes Rev. 2021, 18, 46–55.

[32] Raj, R.; Elshimy, G.; Mishra, R.; Jha, N.; Joseph, V.; Bratman, R.; Tella, S.H.; Correa, R. Dermatologic Manifestations of Endocrine Disorders. Cureus 2021, 13, e18327.

[33] Pavlovi´c, M.D.; Milenkovi´c, T.; Dini´c, M.; Mišovi´c, M.; Dakovi´c, D.; Todorovi´c, S.; Dakovi´c, Z.; Zeˇcevi, R.D.; Doder, R. The Prevalence of Cutaneous Manifestations in Young Patients with Type 1 Diabetes. Diabetes Care 2007, 30, 1964–1967.

[34] Kolkhir, P.; Giménez-Arnau, A.M.; Kulthanan, K.; Peter, J.; Metz, M.; Maurer, M. Urticaria. Nat. Rev. Dis. Prim. 2022, 8, 61.

[35] Confino-Cohen, R.; Chodick, G.; Shalev, V.; Leshno, M.; Kimhi, O.; Goldberg, A. Chronic Urticaria and Autoimmunity: Associations Found in a Large Population Study. J. Allergy Clin. Immunol. 2012, 129, 1307–1313.

[36] Kaplan, A.P.; Greaves, M. Pathogenesis of Chronic Urticaria. Clin. Exp. Allergy 2009, 39, 777–787.

[37] Lin, S.Y.; Lin, C.L.; Lin, C.C.; Hsu, W.H.; Hsu, C.Y.; Kao, C.H. Risk of Urticaria in Children with Type 1 Diabetes Mellitus: A Nationwide Cohort Study. Int. J. Environ. Res. Public Health 2020, 17, 176.

[38] Hyman, S.J.; Shreffler, W.G.; Rapaport, R. Type 1 Diabetes, Autoimmune Thyroid Disease, and Chronic Urticaria. Pediatr. Diabetes 2008, 9, 508–511.

[39] Kim, E.Y.; Shin, C.H.; Yang, S.W. Polymorphisms of HLA Class II Predispose Children and Adolescents with Type 1 Diabetes Mellitus to Autoimmune Thyroid Disease. Autoimmunity 2003, 36, 177–181.

[40] Villasante Fricke, A.C.; Miteva, M. Epidemiology and Burden of Alopecia Areata: A Systematic Review. Clin. Cosmet. Investig. Dermatol. 2015, 8, 397–403.

[41] Juárez-Rendón, K.J.; Sánchez, G.R.; Reyes-López, M.; García-Ortiz, J.E.; Bocanegra-García, V.; Guardiola-Avila, I.; AltamiranoGarcía, M.L. Alopecia Areata. Current Situation and Perspectives. Arch. Argent. Pediatr. 2017, 115, e404–e411.

[42] Hunt, N.; McHale, S. The Psychological Impact of Alopecia. Br. Med. J. 2005, 331, 951–953.

[43] Strazzulla, L.C.; Wang, E.H.C.; Avila, L.; Lo Sicco, K.; Brinster, N.; Christiano, A.M.; Shapiro, J. Alopecia Areata: Disease Characteristics, Clinical Evaluation, and New Perspectives on Pathogenesis. J. Am. Acad. Dermatol. 2018, 78, 1–12.

[44] Tan, E.; Tay, Y.K.; Goh, C.L.; Giam, Y.C. The Pattern and Profile of Alopecia Areata in Singapore—A Study of 219 Asians. Int. J. Dermatol. 2002, 41, 748–753.

[45] Betz, R.C.; Petukhova, L.; Ripke, S.; Huang, H.; Menelaou, A.; Redler, S.; Becker, T.; Heilmann, S.; Yamany, T.; Duvic, M.; et al. Genome-Wide Meta-Analysis in Alopecia Areata Resolves HLA Associations and Reveals Two New Susceptibility Loci. Nat. Commun. 2015, 6, 5966.

[46] Makino, S.; Uchihashi, T.; Kataoka, Y.; Fujiwara, M. Recovery from Alopecia Areata in a Patient with Autoimmune Polyglandular Syndrome Type 3. Endocrinol. Diabetes Metab. Case Rep. 2015, 2015, 140084.

[47] Arousse, A.; Boussofara, L.; Mokni, S.; Gammoudi, R.; Saidi, W.; Aounallah, A.; Belajouza, C.; Ghariani, N.; Denguezli, M.; Nouira, R. Alopecia Areata in Tunisia: Epidemio-Clinical Aspects and Comorbid Conditions. A Prospective Study of 204 Cases. Int. J. Dermatol. 2019, 58, 811–815.

[48] Huang, K.P.; Mullangi, S.; Guo, Y.; Qureshi, A.A. Autoimmune, Atopic, and Mental Health Comorbid Conditions Associated with Alopecia Areata in the United States. JAMA Dermatol. 2013, 149, 789–794.

[49] Noso, S.; Park, C.; Babaya, N.; Hiromine, Y.; Harada, T.; Ito, H.; Taketomo, Y.; Kanto, K.; Oiso, N.; Kawada, A.; et al. Organ Specificity in Autoimmune Diseases: Thyroid and Islet Autoimmunity in Alopecia Areata. J. Clin. Endocrinol. Metab. 2015, 100, 1976–1983.

[50] Griffiths, C.E.M.; Armstrong, A.W.; Gudjonsson, J.E.; Barker, J.N.W.N. Psoriasis. Lancet 2021, 397, 1301–1315.

[51] Rendon, A.; Schäkel, K. Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci. 2019, 20, 1475.

[52] Dand, N.; Mahil, S.K.; Capon, F.; Smith, C.H.; Simpson, M.A.; Barker, J.N. Psoriasis and Genetics. Acta Derm. Venereol. 2020, 100, adv00030.

[53] Takeshita, J.; Grewal, S.; Langan, S.M.; Mehta, N.N.; Ogdie, A.; Van Voorhees, A.S.; Gelfand, J.M. Psoriasis and Comorbid Diseases: Epidemiology. J. Am. Acad. Dermatol. 2017, 76, 377–390.

[54] Wielosz, E.; Majdan, M.; Zychowska, I.; Jeleniewicz, R. Coexistence of Five Autoimmune Diseases: Diagnostic and Therapeutic ˙ Difficulties. Rheumatol. Int. 2008, 28, 919–923.

[55] Christophers, E. Psoriasis: Heterogeneity, Innate Immunity and Comorbidities. Expert Rev. Dermatol. 2012, 7, 195–202.

[56] Caroppo, F.; Galderisi, A.; Moretti, C.; Ventura, L.; Belloni Fortina, A. Prevalence of Psoriasis in a Cohort of Children and Adolescents with Type 1 Diabetes. J. Eur. Acad. Dermatol. Venereol. 2021, 35, e589–e591.

[57] Di Costanzo, L.; Fattorusso, V.; Mozzillo, E.; Patrì, A.; Di Caprio, R.; De Nitto, E.; Balato, N.; Franzese, A. Psoriasis in Children with Type 1 Diabetes: A New Comorbidity to Be Considered? Acta Diabetol. 2017, 54, 803–804.

[58] Vashist, S.; Mahajan, V.; Mehta, K.; Chauhan, P.; Yadav, R.; Sharma, S.; Sharma, V.; Sharma, A.; Chowdhary, B.; Kumar, P. Association of Psoriasis with Autoimmune Disorders: Results of a Pilot Study. Indian Dermatol. Online J. 2020, 11, 753.

[59] Smith, L.L.; Burnet, S.P.; McNeil, J.D. Musculoskeletal Manifestations of Diabetes Mellitus. Br. J. Sport. Med. 2003, 37, 30–35.

[60] Burner, T.W.; Rosenthal, A.K. Diabetes and Rheumatic Diseases. Curr. Opin. Rheumatol. 2009, 21, 50–54.

[61] Gibofsky, A. Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis: A Synopsis. Am. J. Manag. Care 2014, 20, S128–S135.

[62] Karlson, E.W.; Chang, S.C.; Cui, J.; Chibnik, L.B.; Fraser, P.A.; De Vivo, I.; Costenbader, K.H. Gene-Environment Interaction between HLA-DRB1 Shared Epitope and Heavy Cigarette Smoking in Predicting Incident Rheumatoid Arthritis. Ann. Rheum. Dis. 2010, 69, 54–60.

[63] Heliovaara, M.; Aho, K.; Knekt, P.; Impivaara, O.; Reunanen, A.; Aromaa, A. Coffee Consumption, Rheumatoid Factor, and the Risk of Rheumatoid Arthritis. Ann. Rheum. Dis. 2000, 59, 631–635.

[64] Cush, J.J. Rheumatoid Arthritis: Early Diagnosis and Treatment. Med. Clin. N. Am. 2021, 105, 355–365.

[65] Wasserman, A.M. Diagnosis and Management of Rheumatoid Arthritis. Am. Fam. Physician 2011, 84, 1245–1252.

[66] Liao, K.P.; Gunnarsson, M.; Källberg, H.; Ding, B.; Plenge, R.M.; Padyukov, L.; Karlson, E.W.; Klareskog, L.; Askling, J.; Alfredsson, L. Specific Association of Type 1 Diabetes Mellitus with Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis. Arthritis Rheum. 2009, 60, 653–660.

[67] Bao, Y.K.; Salam, M.; Parks, D.; McGill, J.B.; Hughes, J. High Prevalence of Systemic Rheumatic Diseases in Women with Type 1 Diabetes. J. Diabetes Complicat. 2018, 32, 737–739.

[68] Vivino, F.B. Sjogren’s Syndrome: Clinical Aspects. Clin. Immunol. 2017, 182, 48–54.

[69] Jonsson, R.; Brokstad, K.A.; Jonsson, M.V.; Delaleu, N.; Skarstein, K. Current Concepts on Sjögren’s Syndrome—Classification Criteria and Biomarkers. Eur. J. Oral Sci. 2018, 126, 37–48.

[70] Negrini, S.; Emmi, G.; Greco, M.; Borro, M.; Sardanelli, F.; Murdaca, G.; Indiveri, F.; Puppo, F. Sjögren’s Syndrome: A Systemic Autoimmune Disease. Clin. Exp. Med. 2022, 22, 9–25.

[71] Frazzei, G.; van Vollenhoven, R.F.; de Jong, B.A.; Siegelaar, S.E.; van Schaardenburg, D. Preclinical Autoimmune Disease: A Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes. Front. Immunol. 2022, 13, 3207.

[72] Narváez, J. Systemic Lupus Erythematosus 2020. Med. Clin. 2020, 155, 494–501.

[73] Nashi, R.A.; Shmerling, R.H. Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus. Med. Clin. N. Am. 2021, 105, 387–396.

[74] Connelly, K.; Morand, E.F. Systemic Lupus Erythematosus: A Clinical Update. Intern. Med. J. 2021, 51, 1219–1228.

[75] Bao, Y.K.; Weide, L.G.; Ganesan, V.C.; Jakhar, I.; McGill, J.B.; Sahil, S.; Cheng, A.L.; Gaddis, M.; Drees, B.M. High Prevalence of Comorbid Autoimmune Diseases in Adults with Type 1 Diabetes from the HealthFacts Database. J. Diabetes 2019, 11, 273–279.

Downloads

Published

2024-11-25

How to Cite

Majid Abd Ulameer Alhumairi, R., I K Aljuboori, S., Aso Taher, T., & Tariq Sabaar, Z. (2024). Endocrinology and Autoimmune Diabetes. Stallion Journal for Multidisciplinary Associated Research Studies, 3(5), 87–98. https://doi.org/10.55544/sjmars.3.5.10

Issue

Vol. 3 No. 5 (2024): October Issue

Section

Articles

License

Copyright (c) 2024 Stallion Journal for Multidisciplinary Associated Research Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.